Activator protein 1 DNA binding activity is decreased in lesional psoriatic skin compared with nonlesional psoriatic skin

British Journal of Dermatology

Volumn 151, Issue 3, 2004, Pages 600-607

  Johansen, Claus ^a   Kragballe, K ^a   Rasmussen, M ^a   Dam, T N ^a   Iversen, L ^a  

^a AARHUS UNIVERSITY   (Denmark)

Author keywords

Activator protein 1; Psoriasis; Vitamin D

Indexed keywords

CALCIPOTRIOL; DNA; MESSENGER RNA; PROTEIN C JUN; PROTEIN FOS; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR FRA 1;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DNA BINDING; ELECTROPHORETIC MOBILITY; FEMALE; HUMAN; HUMAN TISSUE; MALE; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSORIASIS; SKIN BIOPSY; WESTERN BLOTTING;

ADULT; AGED; BLOTTING, NORTHERN; BLOTTING, WESTERN; CALCITRIOL; DERMATOLOGIC AGENTS; DNA-BINDING PROTEINS; ELECTROPHORETIC MOBILITY SHIFT ASSAY; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MALE; MIDDLE AGED; PROTO-ONCOGENE PROTEINS C-FOS; PROTO-ONCOGENE PROTEINS C-JUN; PSORIASIS; RNA, MESSENGER; SKIN; TRANSCRIPTION FACTOR AP-1;

EID: 4944267474     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2004.06088.x     Document Type: Article

References (27)

1. Weinstein GD, McCullough JL, Ross PA. Cell kinetic basis for pathophysiology of psoriasis. J Invest Dermatol 1985; 85: 579-83.
2. Bernard BA, Asselineau D, Schaffar-Deshayes L et al. Abnormal sequence of expression of differentiation markers in psoriatic epidermis: inversion of two steps in the differentiation program? J Invest Dermatol 1988; 90: 801-5.
3. Kragballe K. Vitamin D analogues in the treatment of psoriasis. J Cell Biochem 1992; 49: 46-52.
4. 3. Endocrinology 1983; 113: 1950-7.
5. 3 on the morphologic and biochemical differentiation of cultured human epidermal keratinocytes grown in serum-free conditions. J Invest Dermatol 1986; 86: 709-14.
6. Haussler MR. Vitamin D receptors: nature and function. Annu Rev Nutr 1986; 6: 527-62.
7. 3. J Cell Biochem 2000; 78: 34-46.
8. 3 in osteoblasts. Steroids 2002; 67: 235-46.
9. 3 stimulates AP-1 DNA binding activity by a PI3-kinase/Ras/MEK/ERK1/2 and JNK1 dependent increase in c-Fos, Fra1 and c-Jun expression in human keratinocytes. J Invest Dermatol 2003; 120: 561-70.
10. 3 which mediates rapid activation of protein kinase C. J Bone Miner Res 1998; 13: 1353-9.
11. 3 induced differentiation of cultured human keratinocytes is accompanied by a PKC-independent regulation of AP-1 DNA binding activity. J Invest Dermatol 2000; 114: 1174-9.
12. 3 stimulates activator protein-1-dependent caco-2 cell differentiation. J Biol Chem 1999; 274: 35505-13.
13. DiSepio D, Jones A, Longley MA et al. The proximal promoter of the mouse loricrin gene contains a functional AP-1 element and directs keratinocyte-specific but not differentiation-specific expression. J Biol Chem 1995; 270: 10792-9.
14. Rutberg SE, Saez E, Glick A et al. Differentiation of mouse keratinocytes is accompanied by PKC-dependent changes in AP-1 proteins. Oncogene 1996; 13: 167-76.
15. Sark MW, Fischer DF, de Meijer E et al. AP-1 and ets transcription factors regulate the expression of the human SPRR1A keratinocyte terminal differentiation marker. J Biol Chem 1998; 273: 24683-92.
16. Angel P. Karin M. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim Biophys Acta 1991; 1072: 129-57.
17. Ng DC, Shafaee S, Lee D et al. Requirement of an AP-1 site in the calcium response region of the involucrin promoter. J Biol Chem 2000; 275: 24080-8.
18. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-54.
19. Basset-Seguin N, Escot C, Moles JP et al. C-fos and c-jun protooncogene expression is decreased in psoriasis: an in situ quantitative analysis. J Invest Dermatol 1991; 97: 672-8.
20. Kragballe K. Calcipotriol for psoriasis. Lancet 1991; 337: 1229-30.
21. Bernerd F, Magnaldo T, Darmon M. Delayed onset of epidermal differentiation in psoriasis. J Invest Dermatol 1992; 98: 902-10.
22. Halazonetis TD, Georgopoulos K, Greenberg ME et al. c-Jun dimerizes with itself and with c-Fos, forming complexes of different DNA binding affinities. Cell 1988; 55: 917-24.
23. Schonthal A, Herrlich P, Rahmsdorf HJ et al. Requirement for fos gene expression in the transcriptional activation of collagenase by other oncogenes and phorbol esters. Cell 1988; 54: 325-34.
24. Robinson CM, Prime SS, Huntley S et al. Overexpression of JunB in undifferentiated malignant rat oral keratinocytes enhances the malignant phenotype in vitro without altering cellular differentiation. Int J Cancer 2001; 91: 625-30.
25. Passegue E, Jochum W, Behrens A et al. JunB can substitute for Jun in mouse development and cell proliferation. Nat Genet 2002; 30: 158-66.
26. Schutte J, Viallet J, Nau M et al. jun-B inhibits and c-fos stimulates the transforming and trans-activating activities of c-jun. Cell 1989; 59: 987-97.
27. Finch S, Joseloff E, Bowden T. JunB negatively regulates AP-1 activity and cell proliferation of malignant mouse keratinocytes. J Cancer Res Clin Oncol 2002; 128: 3-10.